Inventor · disambiguated record
John Patrick Maxwell
Also filed as: MAXWELL JOHN · MAXWELL JOHN P · MAXWELL JOHN PATRICK
44 granted patents·18 pending applications·329 citations·filing 2004–2024
98Inventor score
Top patents by PatentIndex Score
62 records- 0198US9376448B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Jun 28, 2016·46 cites·10 claims
- 0297US11999727B2Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2022·Granted Jun 4, 2024·4 cites·30 claims
- 0397US11492350B2Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2021·Granted Nov 8, 2022·6 cites·20 claims
- 0497US9925188B2DNA-PK inhibitors and uses thereofVERTEX PHARMA·Filed 2016·Granted Mar 27, 2018·24 cites·18 claims
- 0596US9592232B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Mar 14, 2017·24 cites·13 claims
- 0695US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0795US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 0895US9296701B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 29, 2016·21 cites·17 claims
- 0994US9878993B2DNA-PK inhibitors for treatment of cancerVERTEX PHARMA·Filed 2016·Granted Jan 30, 2018·10 cites·7 claims
- 1093US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 1192US11077101B1Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·7 cites·43 claims
- 1292US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 1392US10076521B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Sep 18, 2018·7 cites·21 claims
- 1492US7964624B1Inhibitors of serine proteasesVERTEX PHARMA·Filed 2007·Granted Jun 21, 2011·21 cites·27 claims
- 1592US7365092B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2004·Granted Apr 29, 2008·40 cites·50 claims
- 1691US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 1791US10501439B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Dec 10, 2019·5 cites·18 claims
- 1891US10442791B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Oct 15, 2019·5 cites·13 claims
- 1991US10391095B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Aug 27, 2019·5 cites·9 claims
- 2090US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 2190US7906550B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2008·Granted Mar 15, 2011·7 cites·4 claims
- 2289US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 2389US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 2487US12304907B2Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2024·Granted May 20, 2025·0 cites·24 claims
- 2587US12264154B2Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2024·Granted Apr 1, 2025·0 cites·20 claims
- 2687US7985762B2Inhibitors of serine proteasesVERTEX PHARMA·Filed 2006·Granted Jul 26, 2011·8 cites·54 claims
- 2786US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 2886US8354419B2Benzimidazole analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2010·Granted Jan 15, 2013·10 cites·23 claims
- 2981US8779156B2Analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2012·Granted Jul 15, 2014·7 cites·27 claims
- 3079US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 3179US8163737B2CGRP receptor antagonistsANDERSON COREY·Filed 2007·Granted Apr 24, 2012·6 cites·12 claims
- 3278US12043607B2HDAC inhibitors and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2022·Granted Jul 23, 2024·0 cites·34 claims
- 3378US8440706B2Inhibitors of serine proteasesCOTTRELL KEVIN M·Filed 2011·Granted May 14, 2013·3 cites·12 claims
- 3477US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3576US11813267B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2020·Granted Nov 14, 2023·0 cites·19 claims
- 3676US11021465B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Jun 1, 2021·0 cites·22 claims
- 3775US11008305B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted May 18, 2021·0 cites·20 claims
- 3875US2025136570A1Hdac inhibitors and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3969US8765731B2Benzimidazole analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2012·Granted Jul 1, 2014·1 cites·22 claims
- 4069US8372873B2Inhibitors of serine proteasesVERTEX PHARMA·Filed 2011·Granted Feb 12, 2013·1 cites·23 claims
- 4169US2018311254A1Dna-pk inhibitorsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 4268US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 4364US11986471B2Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2021·Granted May 21, 2024·0 cites·20 claims
- 4464US2016354381A1Dna-pk inhibitorsObligated Assignee·Filed 2016·Application pending·0 cites
- 4563US2025282749A1Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4663US2025171432A1Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4760US2024368139A1Novel modulators of ehmt1 and ehmt2 and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4857US2014243257A1Benzimidazole analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 4954US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 5054US12403137B2Compounds and methods of useTANGO THERAPEUTICS INC·Filed 2020·Granted Sep 2, 2025·0 cites·24 claims
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Patrick Maxwell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →